PMID- 16753805 OWN - NLM STAT- MEDLINE DCOM- 20060914 LR - 20081121 IS - 0300-8207 (Print) IS - 0300-8207 (Linking) VI - 47 IP - 3 DP - 2006 TI - Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells. PG - 124-32 AB - Fibroblast growth factors-2 (FGF-2) and bone morphogenetic protein-2 (BMP-2) are two of the main factors that regulate differentiation of osteoblasts. Interleukin-18 (IL-18), originally cloned as an interferon gamma-inducing factor, has been reported to inhibit maturation of osteoclasts by upregulation of osteoprotegerin secreted from osteoblasts. Little is known about the functional relationship between IL-18 and the two growth factors in osteoblast differentiation. To better understand this relationship, we analyzed the effect of BMP-2 and FGF-2 on the mRNA expression levels of IL-18, as well as IL-1alpha and IL-6, in MC3T3-E1 mouse osteoblastic cells. Following this, the effects of BMP-2 on the expression of IL-18 protein and caspase-1 protein were analyzed by immunofluorescence staining. Real-time PCR and immunofluorescence staining analysis showed that FGF-2 had no effect on the expression of IL-18 mRNA and protein, but while BMP-2 reduced IL-18 mRNA levels, increased immunostaining of both IL-18 protein and caspase-1 protein was detected in BMP-2-treated MC3T3-E1 cells. Although the significance and mechanisms of this counterregulation of IL-18 mRNA and protein were not determined in this study, the increase of IL-18 protein suggested that BMP-2 may induce an active form of IL-18. FAU - Hori, Masateru AU - Hori M AD - Department of Obstetrics and Gynecology, Hyogo College of Medicine, Hyogo, Japan. FAU - Sawai, Hideaki AU - Sawai H FAU - Tsuji, Yoshiyuki AU - Tsuji Y FAU - Okamura, Haruki AU - Okamura H FAU - Koyama, Koji AU - Koyama K LA - eng PT - Journal Article PL - England TA - Connect Tissue Res JT - Connective tissue research JID - 0365263 RN - 0 (Bmp2 protein, mouse) RN - 0 (Bone Morphogenetic Protein 2) RN - 0 (Bone Morphogenetic Proteins) RN - 0 (Interleukin-1) RN - 0 (Interleukin-18) RN - 0 (Interleukin-6) RN - 0 (RNA, Messenger) RN - 0 (Recombinant Proteins) RN - 0 (Transforming Growth Factor beta) RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - EC 3.1.3.1 (Alkaline Phosphatase) RN - EC 3.4.22.36 (Caspase 1) SB - IM MH - Alkaline Phosphatase/metabolism MH - Animals MH - Bone Morphogenetic Protein 2 MH - Bone Morphogenetic Proteins/*pharmacology MH - Caspase 1/metabolism MH - Cell Line MH - Fibroblast Growth Factor 2/pharmacology MH - Gene Expression Regulation/*drug effects MH - Interleukin-1/genetics/metabolism MH - Interleukin-18/*genetics/metabolism MH - Interleukin-6/genetics/metabolism MH - Mice MH - Osteoblasts/*drug effects/metabolism MH - RNA, Messenger/*metabolism MH - Recombinant Proteins/pharmacology MH - Time Factors MH - Transforming Growth Factor beta/*pharmacology EDAT- 2006/06/07 09:00 MHDA- 2006/09/15 09:00 CRDT- 2006/06/07 09:00 PHST- 2006/06/07 09:00 [pubmed] PHST- 2006/09/15 09:00 [medline] PHST- 2006/06/07 09:00 [entrez] AID - VN7316QR30358282 [pii] AID - 10.1080/03008200600685350 [doi] PST - ppublish SO - Connect Tissue Res. 2006;47(3):124-32. doi: 10.1080/03008200600685350.